HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J F Rehfeld Selected Research

Cholecystokinin (Pancreozymin)

1/2018Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity.
1/2017Timeline of changes in appetite during weight loss with a ketogenic diet.
12/2016Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.
5/2010Evaluation of fecal elastase and serum cholecystokinin in dogs with a false positive fecal elastase test.
3/2007Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
2/2001Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.
9/2000Cholecystokinin and panic disorder--three unsettled questions.
7/2000Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter.
6/2000Acute taurodeoxycholate-induced pancreatitis in the rat is associated with hyperCCKemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J F Rehfeld Research Topics

Disease

5Weight Loss (Weight Reduction)
01/2018 - 11/2013
4Type 2 Diabetes Mellitus (MODY)
12/2016 - 01/2013
3Insulin Resistance
02/2016 - 03/2007
3Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 02/2003
3Schizophrenia (Dementia Praecox)
10/2009 - 07/2000
3Panic Disorder (Panic Attack)
01/2006 - 07/2000
3Heart Failure
01/2005 - 06/2003
2Morbid Obesity
01/2018 - 03/2007
2Body Weight (Weight, Body)
01/2018 - 01/2017
2Inflammation (Inflammations)
01/2013 - 03/2007
2Obesity
03/2007 - 03/2007
2Neoplasms (Cancer)
02/2003 - 06/2000
1Exocrine Pancreatic Insufficiency
05/2010
1Hyperinsulinism (Hyperinsulinemia)
03/2007
1Hypertension (High Blood Pressure)
03/2007
1Abdominal Obesity
03/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2007
1Dyslipidemias (Dyslipidemia)
03/2007
1Overweight
03/2007
1Maternal Obesity
03/2007
1Glucose Intolerance
03/2007
1Gastroparesis
09/2006
1Left Ventricular Dysfunction
01/2006
1Depressive Disorder (Melancholia)
01/2006
1Paraplegia (Spastic Paraplegia)
12/2004
1Hypoxia (Hypoxemia)
12/2004
1Cerebellar Ataxia (Dysmetria)
12/2004
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2003
1Fibrosis (Cirrhosis)
06/2003
1Hepatitis
06/2003
1Weight Gain
07/2001
1Colorectal Neoplasms (Colorectal Cancer)
04/2001
1Gallstones (Gallstone)
02/2001
1Birth Weight (Birth Weights)
11/2000
1Pheochromocytoma
11/2000
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2000
1Mental Disorders (Mental Disorder)
07/2000
1Alcoholism (Alcohol Abuse)
07/2000
1Margins of Excision
06/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2000
1Adenocarcinoma
06/2000
1Pancreatitis
06/2000
1Carcinoma (Carcinomatosis)
06/2000
1Edema (Dropsy)
06/2000
1Achlorhydria (Hypochlorhydria)
01/2000

Drug/Important Bio-Agent (IBA)

9Cholecystokinin (Pancreozymin)IBA
01/2018 - 06/2000
7Peptides (Polypeptides)IBA
01/2017 - 06/2000
6Hormones (Hormone)IBA
01/2018 - 03/2007
5GhrelinIBA
01/2018 - 09/2006
4Insulin (Novolin)FDA Link
01/2018 - 03/2007
4Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018 - 01/2016
4GastrinsIBA
03/2007 - 01/2000
3Peptide YYIBA
01/2018 - 11/2016
3Glucose (Dextrose)FDA LinkGeneric
02/2016 - 03/2007
3Cholecystokinin A ReceptorIBA
10/2009 - 06/2000
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2006 - 06/2003
3big gastrinIBA
06/2003 - 01/2000
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
02/2016 - 07/2012
2LipidsIBA
01/2013 - 03/2007
2Biomarkers (Surrogate Marker)IBA
01/2013 - 03/2007
2NeuropeptidesIBA
10/2009 - 07/2000
2C-Reactive ProteinIBA
03/2007 - 03/2007
2Messenger RNA (mRNA)IBA
12/2004 - 06/2000
2Proteins (Proteins, Gene)FDA Link
02/2003 - 06/2000
2Cholecystokinin B ReceptorIBA
09/2000 - 06/2000
1Colesevelam Hydrochloride (Welchol)FDA Link
01/2016
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2013
1Proton Pump InhibitorsIBA
01/2013
1Esomeprazole (Nexium)FDA Link
01/2013
1Pancreatic Elastase (Elastase)IBA
05/2010
1oxidized low density lipoproteinIBA
03/2007
1CholesterolIBA
03/2007
1LDL CholesterolIBA
03/2007
1Neuropeptide YIBA
01/2006
1Endothelin-1 (Endothelin 1)IBA
01/2005
1Endothelins (Endothelin)IBA
01/2005
1SpastinIBA
12/2004
1Oxygen (Dioxygen)IBA
12/2004
18-sulfocholecystokinin octapeptideIBA
07/2001
1Indicators and Reagents (Reagents)IBA
04/2001
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2001
1Octreotide (Sandostatin)FDA LinkGeneric
02/2001
1Blood Glucose (Blood Sugar)IBA
11/2000
1SB 203580IBA
11/2000
1p38 Mitogen-Activated Protein KinasesIBA
11/2000
1ColforsinIBA
11/2000
1AmidesIBA
09/2000
1TetragastrinIBA
09/2000
1EpitopesIBA
06/2000
1LigandsIBA
06/2000
1AmylasesFDA Link
06/2000
1salicylhydroxamic acid (SHAM)IBA
06/2000
1Taurodeoxycholic AcidIBA
06/2000

Therapy/Procedure

4Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2016 - 07/2012
2Therapeutics
06/2003 - 09/2000
1Ketogenic Diet
01/2017
1Injections
07/2001
1Subcutaneous Injections
02/2001
1Analgesia
07/2000